MAPK3 and cancer: ERK1/2, p38 MAPK, and STAT3 signaling cascades have all been shown to mediate the transition from a quiescent fibroblast phenotype to a characteristic CAF phenotype associated with CAF-induced cancer progression, chemoresistance, and immune suppression (46–50).